NASDAQ:ECYT - Nasdaq - US29269A1025
23.99
-0.01 (-0.04%)
The current stock price of ECYT is 23.99 null. In the past month the price increased by 1.78%. In the past year, price increased by 464.47%.
Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based in West Lafayette, Indiana.
ENDOCYTE INC
3000 KENT AVENUE SUITE A1-100
WEST LAFAYETTE IN 47906
CEO: Michael A. Sherman
Phone: 765-463-7175
The current stock price of ECYT is 23.99 null. The price decreased by -0.04% in the last trading session.
The exchange symbol of ENDOCYTE INC is ECYT and it is listed on the Nasdaq exchange.
ECYT stock is listed on the Nasdaq exchange.
ENDOCYTE INC (ECYT) has a market capitalization of 1.97B null. This makes ECYT a Small Cap stock.
ENDOCYTE INC (ECYT) has a support level at 23.9 and a resistance level at 24. Check the full technical report for a detailed analysis of ECYT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ECYT does not pay a dividend.
ENDOCYTE INC (ECYT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.68).
ChartMill assigns a technical rating of 10 / 10 to ECYT. When comparing the yearly performance of all stocks, ECYT is one of the better performing stocks in the market, outperforming 99.72% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to ECYT. ECYT has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months ECYT reported a non-GAAP Earnings per Share(EPS) of -0.6799999999999999. The EPS increased by 38.74% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -32095.26% | ||
ROA | -11.64% | ||
ROE | -11.91% | ||
Debt/Equity | 0 |